Literature DB >> 23917208

Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders.

Tian-Rui Xu1, Yang Yang, Richard Ward, Linghuan Gao, Ying Liu.   

Abstract

The orexin peptides (orexin A, orexin B) and their receptors (orexin receptor type 1, orexin receptor type 2) are involved in multiple physiological processes such as the regulation of sleep/wakefulness state, energy homeostasis and reward seeking. A result of this has been the development of small-molecule orexin receptor antagonists as novel therapies for the treatment of insomnia and drug addiction. Increased levels of signaling via the orexin peptide/receptor system may protect against obesity, while somewhat unexpectedly, orexins acting at orexin receptors induce dramatic apoptosis resulting in the significant reduction of cell growth in various cancer cell lines. Meanwhile, the orexin peptide/receptor system is also involved in cardiovascular modulation, neuroendocrine and reproduction regulation. This review summarizes the latest developments in deciphering the biology of orexin signaling as well as efforts to manipulate orexin signaling pharmacologically.
© 2013.

Entities:  

Keywords:  5-HT; 5-hydroxytryptamine; AC; Addiction; BAT; BMP; BST; CB1R; CNS; CREB; Cancers; DRN; ERK; Energy homeostasis; FAA; G protein coupled receptors; GABA; GH; GPCR; HA; HIF1; HPA; HPG; ICV; ITIM; ITSM; LH; MAPK; NAc; NPY; NSCC; OX1R; OX2R; Orexin receptors; Orexins; OxA; OxB; PH; PKA; PKC; PLC; REM; RN; RVM; SN; Sleep/wakefulness state; Smad; TGF-β; TMN; VTA; adenylyl cyclase; bed nucleus of the stria terminalis; bone morphogenetic protein; brown adipose tissue; cAMP-response element binding protein; cannabinoid receptor type 1; central nervous system; dorsal raphe nucleus; drosophila mothers against decapentaplegic protein; extracellular signal regulated kinase; food anticipatory activity; gamma-aminobutyric acid; growth hormone; histamine; hypothalamic–pituitary–adrenal; hypothalamic–pituitary–gonadal; hypoxia-inducible factor-1; immunoreceptor tyrosine-based inhibitory motif; immunoreceptor tyrosine-based switch motif; intracerebroventricular; lateral hypothalamus; mitogen-activated protein kinase; neuropeptide Y; nonselective cationic conductance; nucleus accumbens; orexin A; orexin B; orexin receptor type 1; orexin receptor type 2; pCREB; phospholipase C; phosphorylated cAMP response element-binding protein; posterior hypothalamus; protein kinase A; protein kinase C; rRPa; raphe nuclei; rapid eye movement; rostral raphe pallidus; rostral ventromedial medulla; substantia nigra; transforming growth factor-β; tuberomammillary nucleus; ventral tegmental area

Mesh:

Substances:

Year:  2013        PMID: 23917208     DOI: 10.1016/j.cellsig.2013.07.025

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  43 in total

1.  Antagonists of Orexin Receptors as Potential Treatment of Sleep Disorders, Obesity, Eating Disorders, and Other Neurological and Psychiatric Disorders.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2016-08-31       Impact factor: 4.345

2.  Plasma orexin A levels in recently menopausal women during and 3 years following use of hormone therapy.

Authors:  Dahima Cintron; John P Beckman; Kent R Bailey; Brian D Lahr; Muthuvel Jayachandran; Virginia M Miller
Journal:  Maturitas       Date:  2017-02-17       Impact factor: 4.342

Review 3.  Targeting orphan G protein-coupled receptors for the treatment of diabetes and its complications: C-peptide and GPR146.

Authors:  G R Kolar; S M Grote; G L C Yosten
Journal:  J Intern Med       Date:  2016-06-16       Impact factor: 8.989

4.  Orexin-A promotes Glu uptake by OX1R/PKCα/ERK1/2/GLT-1 pathway in astrocytes and protects co-cultured astrocytes and neurons against apoptosis in anoxia/hypoglycemic injury in vitro.

Authors:  Qing Shu; Jianhuai Zhang; Wei Ma; Youying Lei; Dan Zhou
Journal:  Mol Cell Biochem       Date:  2016-11-12       Impact factor: 3.396

5.  Gene expression changes in serotonin, GABA-A receptors, neuropeptides and ion channels in the dorsal raphe nucleus of adolescent alcohol-preferring (P) rats following binge-like alcohol drinking.

Authors:  Jeanette N McClintick; William J McBride; Richard L Bell; Zheng-Ming Ding; Yunlong Liu; Xiaoling Xuei; Howard J Edenberg
Journal:  Pharmacol Biochem Behav       Date:  2014-12-24       Impact factor: 3.533

Review 6.  Exploring the Role of Orexinergic Neurons in Parkinson's Disease.

Authors:  Sachin Kumar; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Saurabh Bhatia; Ahmed Al-Harassi; Mohammed M Abdel-Daim; Simona Bungau
Journal:  Neurotox Res       Date:  2021-09-08       Impact factor: 3.911

7.  Crucial role of the orexin-B C-terminus in the induction of OX1 receptor-mediated apoptosis: analysis by alanine scanning, molecular modelling and site-directed mutagenesis.

Authors:  Pascal Nicole; Pierre Couvineau; Nadege Jamin; Thierry Voisin; Alain Couvineau
Journal:  Br J Pharmacol       Date:  2015-09-30       Impact factor: 8.739

8.  PSPH-D-18-00526: Effect of a dual orexin receptor antagonist (DORA-12) on sleep and event-related oscillations in rats exposed to ethanol vapor during adolescence.

Authors:  Cindy L Ehlers; Jessica Benedict; Derek Wills; Manuel Sanchez-Alavez
Journal:  Psychopharmacology (Berl)       Date:  2019-10-28       Impact factor: 4.530

9.  Geotemporospatial and causal inference epidemiological analysis of US survey and overview of cannabis, cannabidiol and cannabinoid genotoxicity in relation to congenital anomalies 2001-2015.

Authors:  Albert Stuart Reece; Gary Kenneth Hulse
Journal:  BMC Pediatr       Date:  2022-01-19       Impact factor: 2.125

10.  [Orexin-A inhibits γ-aminobutyric acid current of neonatal rat spinal cord ventral horn neurons by activating OX1R, OX2R and Ca2+-independent PKC].

Authors:  X Yang; S Zhu; N Jin; Y Li; C Zhen; H Zhang; A Xu; M Wang; C Zheng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.